Nifty

:

17800.30

Sensex

:

60093.00

138.15 (0.78%)
543.10 (0.91%)

Login

Nifty
Sensex

:
:

17800.30
60093.00

138.15 (0.78%)
543.10 (0.91%)

Natco Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

31/99

BSE: 524816 | NSE: NATCOPHARM

Watchlist

NSE BSE

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

9,733.04
23.99
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

9,930.94
0.84%
2.14

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.40
-2.30
0.52

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.80
-22.27
-14.67

PAT CAGR (%)

10 Years
5 Years
3 Years

8.99
-24.57
-28.28

P:E (Median)

8 Years
5 Years
3 Years

35.41
25.83
36.83

P:BV (Average)

8 Years
5 Years
3 Years

5.20
3.57
3.47

EV:EBITDA (Average)

8 Years
5 Years
3 Years

23.78
19.52
23.82

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 351.10 330.40 6.27% 805.70 393.80 104.60% 514.10 311.50 65.04% 529.50 330.90 60.02%
Expenses 281.00 281.00 0.00% 426.30 280.20 52.14% 551.80 235.10 134.71% 441.80 252.70 74.83%
EBITDA 70.10 49.40 41.90% 379.40 113.60 233.98% -37.70 76.40 - 87.70 78.20 12.15%
EBIDTM 19.97% 14.95% 47.09% 28.85% -7.33% 24.53% 16.56% 23.63%
Other Income 16.20 40.30 -59.80% 33.20 12.30 169.92% 10.40 29.10 -64.26% 31.60 24.90 26.91%
Interest 1.70 3.20 -46.88% 2.70 1.80 50.00% 4.20 2.30 82.61% 4.10 3.00 36.67%
Depreciation 38.30 34.20 11.99% 36.90 33.10 11.48% 35.60 29.80 19.46% 35.50 29.40 20.75%
PBT 46.30 52.30 -11.47% 373.00 91.00 309.89% -67.10 73.40 - 79.70 70.70 12.73%
Tax 8.60 -1.30 - 65.00 15.80 311.39% -5.80 16.20 - 8.10 16.00 -49.38%
PAT 37.70 53.60 -29.66% 308.00 75.20 309.57% -61.30 57.20 - 71.60 54.70 30.90%
PATM 10.74% 16.22% 38.23% 19.10% -11.92% 18.36% 13.52% 16.53%
EPS 2.06 2.94 -29.93% 16.87 4.12 309.47% -3.36 3.13 - 3.92 3.00 30.67%

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 432.10 377.20 14.55% 884.60 410.30 115.60% 596.80 331.30 80.14% 560.50 355.20 57.80%
Expenses 336.80 306.70 9.81% 489.30 300.50 62.83% 615.40 255.10 141.24% 458.70 272.70 68.21%
EBITDA 95.30 70.50 35.18% 395.30 109.80 260.02% -18.60 76.20 - 101.80 82.50 23.39%
EBIDTM 22.06% 18.69% 44.69% 26.76% -3.12% 23.00% 18.16% 23.23%
Other Income 20.50 38.00 -46.05% 34.30 17.00 101.76% 13.80 28.40 -51.41% 30.20 30.80 -1.95%
Interest 3.80 4.00 -5.00% 4.20 2.00 110.00% 6.70 3.50 91.43% 5.00 3.40 47.06%
Depreciation 41.70 34.70 20.17% 39.60 33.80 17.16% 38.10 30.40 25.33% 36.00 29.80 20.81%
PBT 70.30 69.80 0.72% 385.80 91.00 323.96% -49.60 70.70 - 91.00 80.10 13.61%
Tax 13.50 4.70 187.23% 65.40 16.00 308.75% 0.90 17.70 -94.92% 10.60 16.70 -36.53%
PAT 56.80 65.10 -12.75% 320.40 75.00 327.20% -50.50 53.00 - 80.40 63.40 26.81%
PATM 13.15% 17.26% 36.22% 18.28% -8.46% 16.00% 14.34% 17.85%
EPS 3.11 3.57 -12.89% 17.56 4.11 327.25% -2.77 2.90 - 4.41 3.45 27.83%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 2,200.40 1,767.80 1,653.50 1,790.20 1,986.30 2,091.30 1,958.00 1,021.40 715.55 622.34 557.85 Net Sales Growth 61.01% 6.91% -7.64% -9.87% -5.02% 6.81% 91.70% 42.74% 14.98% 11.56% Cost Of Goods Sold 572.00 502.10 472.30 369.80 317.60 388.50 572.80 256.30 170.70 150.73 164.96 Gross Profit 1,628.40 1,265.70 1,181.20 1,420.40 1,668.70 1,702.80 1,385.20 765.10 544.85 471.61 392.89 GP Margin 74.00% 71.60% 71.44% 79.34% 84.01% 81.42% 70.75% 74.91% 76.14% 75.78% 70.43% Total Expenditure 1,700.90 1,554.80 1,238.30 1,212.20 1,169.80 1,162.90 1,266.00 740.70 486.99 435.76 400.92 Power & Fuel Cost - 76.40 59.40 62.40 59.60 56.10 50.50 43.70 40.49 40.69 36.98 % Of Sales - 4.32% 3.59% 3.49% 3.00% 2.68% 2.58% 4.28% 5.66% 6.54% 6.63% Employee Cost - 410.10 380.00 356.10 340.20 312.20 232.10 171.90 116.19 94.22 85.36 % Of Sales - 23.20% 22.98% 19.89% 17.13% 14.93% 11.85% 16.83% 16.24% 15.14% 15.30% Manufacturing Exp. - 340.80 160.50 230.40 257.50 175.10 134.20 100.60 65.41 70.48 61.85 % Of Sales - 19.28% 9.71% 12.87% 12.96% 8.37% 6.85% 9.85% 9.14% 11.32% 11.09% General & Admin Exp. - 122.50 92.60 111.20 103.90 96.00 78.30 56.90 48.57 46.44 31.60 % Of Sales - 6.93% 5.60% 6.21% 5.23% 4.59% 4.00% 5.57% 6.79% 7.46% 5.66% Selling & Distn. Exp. - 27.00 29.20 22.60 33.50 98.00 128.80 88.40 34.29 24.47 13.46 % Of Sales - 1.53% 1.77% 1.26% 1.69% 4.69% 6.58% 8.65% 4.79% 3.93% 2.41% Miscellaneous Exp. - 75.90 44.30 59.70 57.50 37.00 69.30 22.90 11.33 8.73 13.46 % Of Sales - 4.29% 2.68% 3.33% 2.89% 1.77% 3.54% 2.24% 1.58% 1.40% 1.20% EBITDA 499.50 213.00 415.20 578.00 816.50 928.40 692.00 280.70 228.56 186.58 156.93 EBITDA Margin 22.70% 12.05% 25.11% 32.29% 41.11% 44.39% 35.34% 27.48% 31.94% 29.98% 28.13% Other Income 91.40 94.60 103.50 123.80 129.80 39.40 13.20 12.90 13.57 15.71 11.94 Interest 12.70 13.30 11.30 20.60 18.80 14.70 17.50 21.90 30.13 34.06 25.12 Depreciation 146.30 138.40 115.20 98.10 80.10 65.50 53.60 50.20 42.46 26.79 19.84 PBT 431.90 155.90 392.20 583.10 847.40 887.60 634.10 221.50 169.54 141.45 123.91 Tax 75.90 16.80 82.70 108.60 180.30 189.40 139.30 45.00 1.48 31.26 34.18 Tax Rate 17.57% 10.78% 21.09% 18.62% 21.28% 21.34% 21.97% 20.32% 0.96% 22.10% 30.43% PAT 356.00 139.10 309.50 474.50 667.10 698.20 494.80 176.50 152.93 110.19 78.14 PAT before Minority Interest 356.00 139.10 309.50 474.50 667.10 698.20 494.80 176.50 152.93 110.19 78.14 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 16.18% 7.87% 18.72% 26.51% 33.59% 33.39% 25.27% 17.28% 21.37% 17.71% 14.01% PAT Growth 47.90% -55.06% -34.77% -28.87% -4.45% 41.11% 180.34% 15.41% 38.79% 41.02% EPS 19.50 7.62 16.95 25.99 36.53 38.24 27.10 9.67 8.38 6.03 4.28

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 2,474.00 1,944.80 2,052.10 1,915.00 2,094.50 2,184.80 2,020.20 1,141.30 825.28 738.89 660.53 Net Sales Growth 67.84% -5.23% 7.16% -8.57% -4.13% 8.15% 77.01% 38.29% 11.69% 11.86% Cost Of Goods Sold 642.80 528.40 483.70 354.40 332.70 411.10 599.10 341.10 242.37 233.23 242.80 Gross Profit 1,831.20 1,416.40 1,568.40 1,560.60 1,761.80 1,773.70 1,421.10 800.20 582.90 505.67 417.73 GP Margin 74.02% 72.83% 76.43% 81.49% 84.12% 81.18% 70.34% 70.11% 70.63% 68.44% 63.24% Total Expenditure 1,900.20 1,681.30 1,448.30 1,332.40 1,299.70 1,256.40 1,336.80 868.70 611.90 559.56 510.60 Power & Fuel Cost - 76.40 61.10 62.40 59.60 56.20 50.50 43.70 43.24 44.77 38.75 % Of Sales - 3.93% 2.98% 3.26% 2.85% 2.57% 2.50% 3.83% 5.24% 6.06% 5.87% Employee Cost - 444.80 414.90 375.00 355.90 325.60 243.20 189.60 136.92 112.77 102.29 % Of Sales - 22.87% 20.22% 19.58% 16.99% 14.90% 12.04% 16.61% 16.59% 15.26% 15.49% Manufacturing Exp. - 344.90 165.70 243.30 276.40 182.60 141.20 105.20 73.04 76.57 65.10 % Of Sales - 17.73% 8.07% 12.70% 13.20% 8.36% 6.99% 9.22% 8.85% 10.36% 9.86% General & Admin Exp. - 161.50 242.90 132.60 126.40 105.50 88.10 73.40 63.66 56.21 39.49 % Of Sales - 8.30% 11.84% 6.92% 6.03% 4.83% 4.36% 6.43% 7.71% 7.61% 5.98% Selling & Distn. Exp. - 43.70 34.40 98.10 90.00 136.90 143.20 91.60 37.36 26.16 14.82 % Of Sales - 2.25% 1.68% 5.12% 4.30% 6.27% 7.09% 8.03% 4.53% 3.54% 2.24% Miscellaneous Exp. - 81.60 45.60 66.60 58.70 38.50 71.50 24.10 15.31 9.85 14.82 % Of Sales - 4.20% 2.22% 3.48% 2.80% 1.76% 3.54% 2.11% 1.86% 1.33% 1.11% EBITDA 573.80 263.50 603.80 582.60 794.80 928.40 683.40 272.60 213.38 179.33 149.93 EBITDA Margin 23.19% 13.55% 29.42% 30.42% 37.95% 42.49% 33.83% 23.89% 25.86% 24.27% 22.70% Other Income 98.80 99.00 106.00 107.40 130.20 40.40 13.90 9.90 14.91 16.71 12.41 Interest 19.70 17.70 13.30 21.50 19.30 15.40 18.50 22.90 31.68 36.62 26.31 Depreciation 155.40 142.60 116.90 99.80 81.00 66.20 54.40 51.00 47.27 30.44 22.12 PBT 497.50 202.20 579.60 568.70 824.70 887.20 624.40 208.60 149.34 128.98 113.90 Tax 90.40 32.20 137.20 110.60 182.30 192.00 139.50 52.80 3.95 30.87 36.44 Tax Rate 18.17% 15.92% 23.67% 19.45% 22.11% 21.64% 22.34% 25.31% 2.94% 23.93% 35.61% PAT 407.10 170.00 440.90 460.80 644.40 696.20 486.00 157.10 134.62 102.74 71.87 PAT before Minority Interest 407.10 170.00 442.40 458.10 642.40 695.20 484.90 155.80 130.27 98.11 65.88 Minority Interest 0.00 0.00 -1.50 2.70 2.00 1.00 1.10 1.30 4.35 4.63 5.99 PAT Margin 16.46% 8.74% 21.49% 24.06% 30.77% 31.87% 24.06% 13.77% 16.31% 13.90% 10.88% PAT Growth 58.71% -61.44% -4.32% -28.49% -7.44% 43.25% 209.36% 16.70% 31.03% 42.95% EPS 22.29 9.31 24.15 25.24 35.29 38.13 26.62 8.60 7.37 5.63 3.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 4,191.90 4,091.10 3,869.50 3,563.20 3,125.40 1,699.70 1,336.30 878.99 732.90 537.58 Share Capital 36.50 36.50 36.40 36.50 36.90 34.90 34.80 33.23 33.07 31.37 Total Reserves 4,151.90 4,037.00 3,809.50 3,495.80 3,064.30 1,649.40 1,291.80 845.76 699.83 506.21 Non-Current Liabilities 134.90 142.90 117.50 83.10 47.00 37.70 27.90 117.53 148.62 187.15 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 96.28 94.97 137.07 Unsecured Loans 0.00 0.00 0.90 0.00 0.00 0.00 0.00 0.00 0.00 0.05 Long Term Provisions 95.70 99.60 90.20 71.00 32.40 21.90 12.50 9.19 10.63 8.21 Current Liabilities 651.20 518.50 659.70 709.80 563.80 609.70 478.50 398.31 294.71 332.75 Trade Payables 141.20 139.50 234.20 201.80 245.40 251.40 270.10 115.34 99.18 96.38 Other Current Liabilities 104.00 111.10 93.40 108.50 131.70 122.80 110.90 113.32 96.48 88.30 Short Term Borrowings 389.00 255.10 313.10 384.50 173.00 220.60 96.00 168.54 98.63 147.74 Short Term Provisions 17.00 12.80 19.00 15.00 13.70 14.90 1.50 1.11 0.41 0.33 Total Liabilities 4,978.00 4,752.50 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70 1,394.83 1,176.23 1,057.48 Net Block 2,174.20 2,005.90 1,574.50 1,214.90 1,015.30 829.00 705.60 572.74 528.98 470.56 Gross Block 2,977.80 2,678.30 2,133.70 1,678.20 1,399.60 1,151.00 975.90 783.12 690.82 605.69 Accumulated Depreciation 803.60 672.40 559.20 463.30 384.30 322.00 270.30 210.39 161.84 135.13 Non Current Assets 2,799.80 2,584.00 2,406.80 2,088.70 1,682.00 1,312.00 1,051.80 950.65 838.88 748.95 Capital Work in Progress 128.70 223.40 517.80 637.50 480.00 336.20 211.90 100.77 92.94 78.37 Non Current Investment 430.40 294.90 186.10 117.60 101.30 85.90 71.70 131.15 88.58 76.76 Long Term Loans & Adv. 61.90 55.60 124.30 110.40 83.10 60.40 62.00 142.47 125.16 120.66 Other Non Current Assets 4.60 4.20 4.10 8.30 2.30 0.50 0.60 3.52 3.22 2.61 Current Assets 2,178.20 2,168.50 2,239.90 2,267.40 2,054.20 1,035.10 790.90 444.18 337.35 308.52 Current Investments 119.60 42.10 5.00 126.80 48.30 8.90 22.10 0.12 0.32 0.81 Inventories 697.70 769.20 524.40 508.40 425.80 336.90 351.90 198.35 161.97 128.32 Sundry Debtors 575.60 399.80 536.70 491.60 606.00 468.90 255.80 188.96 115.85 126.46 Cash & Bank 100.90 262.80 54.10 262.70 172.10 25.10 40.20 7.19 7.70 7.50 Other Current Assets 684.40 95.20 93.80 108.40 802.00 195.30 120.90 49.57 51.53 45.42 Short Term Loans & Adv. 606.30 599.40 1,025.90 769.50 748.80 169.60 95.50 43.99 47.35 41.32 Net Current Assets 1,527.00 1,650.00 1,580.20 1,557.60 1,490.40 425.40 312.40 45.87 42.64 -24.23 Total Assets 4,978.00 4,752.50 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70 1,394.83 1,176.23 1,057.47

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 4,263.60 4,121.60 3,773.50 3,489.00 3,072.20 1,649.30 1,295.70 846.05 725.88 533.54 Share Capital 36.50 36.50 36.40 36.50 36.90 34.90 34.80 33.23 33.07 31.37 Total Reserves 4,223.70 4,067.60 3,713.60 3,421.70 3,011.40 1,599.00 1,251.20 812.82 692.80 502.17 Non-Current Liabilities 135.10 142.90 117.80 83.40 47.10 37.70 28.00 119.23 150.67 191.46 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 94.03 92.20 135.62 Unsecured Loans 0.00 0.00 0.90 0.00 0.00 0.00 0.00 2.99 3.28 2.21 Long Term Provisions 95.70 99.60 90.20 71.00 32.40 21.90 12.50 9.50 11.09 8.62 Current Liabilities 710.40 525.60 685.30 728.70 592.00 626.50 493.10 413.74 312.28 344.87 Trade Payables 161.80 146.20 255.40 217.00 269.10 262.70 275.60 125.30 109.79 105.85 Other Current Liabilities 126.70 99.50 95.90 109.80 133.40 127.10 114.20 118.56 102.18 90.21 Short Term Borrowings 404.00 265.80 315.00 386.30 173.20 221.60 98.40 168.54 98.63 147.74 Short Term Provisions 17.90 14.10 19.00 15.60 16.30 15.10 4.90 1.33 1.69 1.07 Total Liabilities 5,109.10 4,791.90 4,587.80 4,303.10 3,715.10 2,317.60 1,821.70 1,384.05 1,195.71 1,080.41 Net Block 2,311.80 2,023.20 1,584.40 1,227.20 1,018.60 833.00 710.10 709.97 644.74 582.75 Gross Block 3,126.90 2,702.10 2,148.70 1,694.50 1,407.60 1,158.70 983.30 939.98 819.89 726.97 Accumulated Depreciation 815.10 678.90 564.30 467.30 389.00 325.70 273.20 225.82 171.11 140.57 Non Current Assets 2,611.90 2,447.10 2,262.20 1,955.90 1,584.40 1,230.30 984.70 901.08 827.57 749.94 Capital Work in Progress 129.50 223.40 518.00 637.60 480.00 336.30 211.80 128.96 123.78 105.84 Non Current Investment 104.40 151.90 83.60 19.90 8.10 0.10 0.10 1.57 1.57 1.54 Long Term Loans & Adv. 61.50 44.30 72.00 62.80 75.40 60.40 62.10 57.03 54.25 57.20 Other Non Current Assets 4.70 4.30 4.20 8.40 2.30 0.50 0.60 3.54 3.24 2.61 Current Assets 2,497.20 2,344.80 2,325.60 2,347.20 2,130.70 1,087.30 837.00 482.97 368.14 330.48 Current Investments 203.70 151.80 28.70 148.70 68.40 32.10 22.10 0.12 0.32 0.81 Inventories 762.00 798.20 558.00 529.00 438.40 348.90 357.30 220.00 181.12 146.02 Sundry Debtors 620.60 412.90 551.30 506.20 637.50 475.20 261.60 192.43 118.80 129.71 Cash & Bank 206.10 283.50 66.00 279.50 183.70 35.80 45.20 13.36 11.05 10.78 Other Current Assets 704.80 94.70 91.60 107.40 802.70 195.30 150.80 57.06 56.85 43.14 Short Term Loans & Adv. 616.70 603.70 1,030.00 776.40 749.50 169.50 125.40 40.97 52.46 38.85 Net Current Assets 1,786.80 1,819.20 1,640.30 1,618.50 1,538.70 460.80 343.90 69.23 55.85 -14.39 Total Assets 5,109.10 4,791.90 4,587.80 4,303.10 3,715.10 2,317.60 1,821.70 1,384.05 1,195.71 1,080.42

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 57.70 183.50 422.50 698.80 476.40 329.80 189.90 124.55 171.79 70.02 PBT 155.90 392.20 583.10 847.40 887.60 634.10 221.50 154.41 141.45 112.33 Adjustment 118.50 58.40 45.20 12.10 74.40 99.80 81.70 62.73 56.69 45.53 Changes in Working Capital -184.20 -190.20 -100.70 14.20 -281.20 -281.70 -68.50 -72.49 6.11 -65.58 Cash after chg. in Working capital 90.20 260.40 527.60 873.70 680.80 452.20 234.70 144.64 204.25 92.27 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -32.50 -76.90 -105.10 -174.90 -204.40 -122.40 -44.80 -20.09 -32.46 -22.24 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -92.50 -3.20 -165.00 -645.20 -1,131.10 -290.60 -249.30 -147.95 -130.64 -124.24 Net Fixed Assets -204.80 -250.20 -335.80 -436.10 -392.40 -299.40 -303.91 -100.13 -99.70 -102.47 Net Investments -213.00 -145.90 53.30 -94.80 -54.80 -1.00 37.47 -42.37 -11.33 -2.67 Others 325.30 392.90 117.50 -114.30 -683.90 9.80 17.14 -5.45 -19.61 -19.10 Cash from Financing Activity 35.60 -183.10 -261.10 -52.20 652.00 -45.60 151.40 22.80 -40.96 29.17 Net Cash Inflow / Outflow 0.80 -2.80 -3.60 1.40 -2.70 -6.40 92.00 -0.59 0.19 -25.04 Opening Cash & Equivalents 5.10 7.90 11.50 10.10 12.80 19.20 -170.00 6.86 6.67 31.71 Closing Cash & Equivalent 5.90 5.10 7.90 11.50 10.10 12.80 -76.80 6.27 6.86 6.67

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 46.50 298.80 417.30 668.80 463.60 345.80 112.20 92.67 144.03 61.19 PBT 202.20 579.60 568.70 824.70 887.20 624.40 208.60 134.22 128.98 102.32 Adjustment 123.90 62.10 54.00 14.30 75.60 100.20 90.50 68.14 65.72 48.87 Changes in Working Capital -231.40 -212.90 -97.60 8.60 -294.60 -253.00 -140.70 -85.96 -16.11 -67.39 Cash after chg. in Working capital 94.70 428.80 525.10 847.60 668.20 471.60 158.40 116.41 178.58 83.80 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -48.20 -130.00 -107.80 -178.80 -204.60 -125.80 -46.20 -23.74 -34.55 -22.61 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -5.30 -103.30 -167.00 -612.20 -1,115.50 -299.40 -175.50 -114.75 -108.92 -107.07 Net Fixed Assets -204.80 -250.20 -335.80 -436.10 -392.40 -299.40 -303.91 -100.13 -99.70 -102.47 Net Investments -213.00 -145.90 53.30 -94.80 -54.80 -1.00 37.47 -42.37 -11.33 -2.67 Others 412.50 292.80 115.50 -81.30 -668.30 1.00 90.94 27.75 2.11 -1.93 Cash from Financing Activity 34.80 -185.70 -250.80 -50.90 650.90 -47.70 154.00 29.07 -35.27 26.31 Net Cash Inflow / Outflow 76.00 9.80 -0.50 5.70 -1.00 -1.30 90.70 6.99 -0.15 -19.57 Opening Cash & Equivalents 25.80 19.80 28.30 21.70 23.50 24.20 -164.10 10.22 9.95 34.64 Closing Cash & Equivalent 111.10 25.80 19.80 28.30 21.70 23.50 -74.20 12.44 10.22 9.95

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 229.50 223.21 211.31 193.55 168.09 96.52 76.24 52.90 221.60 171.35 ROA 2.86% 6.59% 10.54% 16.49% 22.95% 23.62% 10.90% 11.90% 9.87% 8.03% ROE 3.37% 7.82% 12.86% 20.11% 29.18% 32.87% 16.00% 18.97% 17.35% 15.55% ROCE 3.79% 9.46% 14.85% 23.91% 34.58% 38.71% 18.48% 17.10% 19.04% 17.19% Fixed Asset Turnover 0.65 0.70 0.99 1.41 1.65 1.88 1.20 0.99 0.97 1.10 Receivable days 96.61 101.41 99.38 92.04 93.04 66.04 76.63 76.52 70.40 70.98 Inventory Days 145.29 140.07 99.81 78.34 66.02 62.77 94.81 90.45 84.34 72.86 Payable days 102.03 144.40 66.65 73.69 81.82 79.78 95.04 82.23 86.11 84.32 Cash Conversion Cycle 139.87 97.08 132.54 96.69 77.23 49.02 76.39 84.74 68.63 59.52 Total Debt/Equity 0.09 0.06 0.08 0.11 0.06 0.13 0.08 0.35 0.32 0.62 Interest Cover 12.72 35.71 29.31 46.07 61.38 37.23 11.11 6.12 5.15 5.47

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 233.44 224.88 206.04 189.49 165.22 93.63 73.91 50.91 219.48 170.06 ROA 3.43% 9.43% 10.30% 16.02% 23.05% 23.43% 9.72% 10.10% 8.62% 6.64% ROE 4.06% 11.27% 12.71% 19.75% 29.70% 33.21% 14.62% 16.57% 15.58% 13.08% ROCE 4.86% 13.99% 14.82% 23.71% 35.28% 39.21% 18.04% 15.62% 18.02% 16.04% Fixed Asset Turnover 0.76 0.86 1.07 1.47 1.72 1.93 1.23 0.95 0.96 1.14 Receivable days 85.10 84.44 93.77 91.36 92.22 65.12 70.27 67.76 60.90 61.30 Inventory Days 128.47 118.77 96.38 77.28 65.25 62.41 89.35 87.33 80.17 70.04 Payable days 106.38 151.52 65.96 72.53 81.42 78.30 85.42 73.36 74.09 73.36 Cash Conversion Cycle 107.20 51.68 124.19 96.11 76.05 49.23 74.21 81.73 66.99 57.98 Total Debt/Equity 0.09 0.06 0.08 0.11 0.06 0.14 0.09 0.37 0.33 0.63 Interest Cover 12.42 44.58 27.45 43.73 58.61 34.75 10.11 5.24 4.52 4.89

Top Investors:

life insurance coporation of india

icici prudential multicap fund

mirae asset emerging bluechip fund

plenty private equity fii i limited

nomura singapore limited

Annual Reports:

News Update:

Natco Pharma - Quarterly Results
22nd Nov 2022, 16:26 PM

Read More
Natco Pharma launches first generic version of Pomalyst Capsules in Australian market
9th Nov 2022, 11:39 AM

Pomalyst registered sales of $35.6 million in the Australian market for the year ending March 31, 2022 as per industry sales data
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback